Myovant Sciences Revenue

Biotechnology Research • Brisbane, California, United States • 51-100 Employees

Myovant Sciences revenue & valuation

Annual revenue	$490,800,000
Revenue per employee	$5,843,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,570,600,000
Total funding	$200,000,000

Key Contacts at Myovant Sciences

Shanel Anthony

Regional Sales Director

Sang Lee

Director, Commercial Operations

Raymond Mckinney

Senior Director, Quality It & Csv

Joshua Larkin

Director, Program Management

Arleen Ma

Director, Healthcare Compliance

Brian Irvin

Associate Director, Quality Control

Kim Miller

Associate Director, Medical Writing

Ahmed Mughal

Owner

Company overview

Headquarters	2000 Sierra Point Parkway, 9th Floor, Brisbane, CA 94005, US
Phone number	+16502380250
Website	myovant.com
NAICS	541714
Founded	2016
Employees	51-100
Socials

Myovant Sciences Email Formats

Myovant Sciences uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@myovant.com), used 52.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@myovant.com	52.9%
{first initial}.{last name}	j.doe@myovant.com	47.1%

About Myovant Sciences

This page is no longer active or monitored. Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive. Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

Director

Employees by Department

Myovant Sciences has 30 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Myovant Sciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-09-05	16	$200,000,000

Funding Insights

$200,000,000

Total funding amount

$200,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Myovant Sciences is located in Brisbane, California, US.

You can reach Myovant Sciences at +16502380250.

Myovant Sciences generates an estimated annual revenue of $490,784,000. This revenue figure reflects the company's market position and business performance in its industry.

Myovant Sciences has an estimated valuation of $1,570,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Myovant Sciences was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Myovant Sciences has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Myovant Sciences has raised a total of $200,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.